NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

臨床試驗管理系統的全球市場 (∼2025年):各產品 (軟體、服務)、部署區分 (網站、內部部署、雲端)、引進區分 (企業、現場)、終端用戶 (製藥、醫療設備製造商、CRO)、地區

Clinical Trial Management System Market by Product (Software, Services), Delivery (Web-hosted, On-premise, Cloud-based), Deployment (Enterprise, On-site), End User (Pharma, Medical Device Manufacturers, CROs) - Global Forecasts to 2025

出版商 MarketsandMarkets 商品編碼 986080
出版日期 內容資訊 英文 147 Pages
訂單完成後即時交付
價格
臨床試驗管理系統的全球市場 (∼2025年):各產品 (軟體、服務)、部署區分 (網站、內部部署、雲端)、引進區分 (企業、現場)、終端用戶 (製藥、醫療設備製造商、CRO)、地區 Clinical Trial Management System Market by Product (Software, Services), Delivery (Web-hosted, On-premise, Cloud-based), Deployment (Enterprise, On-site), End User (Pharma, Medical Device Manufacturers, CROs) - Global Forecasts to 2025
出版日期: 2021年01月29日內容資訊: 英文 147 Pages
簡介

臨床試驗管理系統的市場規模在預測期間內預計以14.7%的年複合成長率發展,從2020年的8億100萬美元,成長到2025年15億9000萬美元的規模。產學聯合的高漲,臨床試驗數增加,技術引進的擴大,政府對研究實驗的輔助等要素促進該市場的成長。另一方面,預算上的限制,先進的解決方案的知識不足等課題妨礙市場進一步成長。

本報告提供全球臨床試驗管理系統的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的變化、預測,引進區分、展開區分、產品&服務、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
    • 主要趨勢
  • COVID-19的影響
  • 親市場:醫療IT解決方案
  • 親市場:主要的使用案例

第6章 市場分析、預測:各引進種類

  • 企業
  • 現場

第7章 市場分析、預測:各展開種類

  • 網站(按需)
  • 內部部署
  • 雲端基礎

第8章 市場分析、預測:各產品、服務

  • 軟體
  • 服務

第9章 市場分析、預測:各終端用戶

  • 大規模製藥、生物科技企業
  • CRO
  • 醫療設備製造商
  • 中小規模製藥、生物科技企業
  • 其他

第10章 市場分析、預測:各地區、主要國家

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 南美
  • 中東、非洲

第11章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭模式
  • 競爭領導製圖

第12章 企業簡介

  • ORACLE
  • MEDIDATA SOLUTIONS
  • PAREXEL INTERNATIONAL CORPORATION
  • IBM
  • BIOCLINICA
  • BIO-OPTRONICS
  • DATATRAK INTERNATIONAL
  • VEEVA SYSTEMS
  • MASTERCONTROL
  • DSG
  • ERT
  • ADVARRA TECHNOLOGY SOLUTIONS
  • MEDNET SOLUTIONS
  • ARISGLOBAL
  • DZS CLINICAL SERVICES (WDB HOLDINGS CO. LTD)
  • 新興企業、Start-Ups
    • CRUCIAL DATA SOLUTIONS (CDS)
    • ENNOV
    • DATASTAT
    • BSI
    • REALTIME SOFTWARE SOLUTIONS LLC

第13章 附錄

目錄
Product Code: HIT 1686

The clinical trial management system market is projected to reach USD 1,590 Million by 2025 from USD 801 Million in 2020, at a CAGR of 14.7% during the forecast period. The growth of the CTMS market is driven by rising industry-academia collaborations, the increasing number of clinical trials, rising technology adoption, and government support for research trials. However, budget constraints and limited knowledge about advanced CTMS solutions restrain the market growth

"In terms deployment mode, enterprise-wide segment to register significant growth during the forecast period."

Based on the deployment mode, the clinical trial management system market is segmented into enterprise-wide and on-site CTMS. The enterprise-wide segment accounted for the largest share in the year 2019. The large share of this segment can be attributed to its widespread adoption by the majority of end users due to its benefits.

In terms delivery mode, web-based (on demand) segment to register significant growth during the forecast period."

Based on the delivery mode, the clinical trial management system market is segmented into web-based (on demand), licensed enterprise (on-premise), and cloud-based (SaaS) . The web-based (on demand) segment accounted for the largest share in the year 2019. The large share of this segment can be attributed to the advantages offered by web-based software, such as easy access, improved productivity, and time and cost-efficiency.

"In terms of products & service, software segment to register significant growth during the forecast period."

Based on the product & service, the clinical trial management system market is segmented into software and service. Rising R&D expenditure, an increasing number of clinical trials, and the growing adoption of clinical trial management solutions are some of the key factors driving the growth of the software market

"Large pharma-biotech companies segment is expected to account for the largest share of the clinical trial management system market, by the end user" `

The clinical trial management system market has been segmented based on end-user category-large pharma-biotech companies, small & mid-sized pharma-biotech companies, CROs, medical device manufacturers, and other end users. Large pharma-biotech companies segment accounted the highest market share in the year 2019. The CROs segment holds the second-largest market share; it is projected to register the second-highest CAGR during the forecast period.

"Asia Pacific market is expected to grow at the highest CAGR during the forecast period."

The Asia Pacific market is projected to register the highest CAGR during the forecast period. In 2019, Asia Pacific region is expected to offer significant opportunities for the growth of the clinical trial management system market. The major factors driving the growth of the Asia Pacific market include increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines as compared to developed nations, a large patient base, faster rate of patient recruitment for clinical trials than mature nations, low operating costs for conducting clinical trials, a shortage of trial volunteers in Europe and North America, and the growing number of pharmaceutical companies and CROs in the region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
  • By Designation: C-level-10%, Director-level-14%, and Others-76%
  • By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, and the Middle East & Africa-3%

Some of the prominent players in the clinical trial management system market include Oracle Corporation (US), Medidata Solutions (US), Parexel International (US), Bioclinica (US), IBM (US) Bio-Optronics (US), Datatrak (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Advarra Technology Solutions (US), MedNet Solutions (US), ArisGlobal (US), DZS Clinical Services (US), Crucial Data Solutions (US), Ennov (France), DataStat (US), and RealTime Software Solutions LLC (US), among others.

Research Coverage

This report studies the clinical trial management system market based on deployment, delivery, product & service, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the clinical trial management system market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the clinical trial management system market

Market Development: Comprehensive information on lucrative emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the clinical trial management system market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 MAJOR MARKET STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES: CLINICAL TRIAL MANAGEMENT SYSTEM MARKET
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 END USER-BASED MARKET ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: CLINICAL TRIAL MANAGEMENT SYSTEM MARKET
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 6 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY PRODUCT AND SERVICE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 7 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 8 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY DELIVERY MODE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 9 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE CLINICAL TRIAL MANAGEMENT SYSTEM MARKET

4 PREMIUM INSIGHTS

  • 4.1 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET OVERVIEW
    • FIGURE 11 INCREASING RESEARCH PARTNERSHIPS AND OUTSOURCING ARE DRIVING GROWTH IN THE CTMS MARKET
  • 4.2 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE
    • FIGURE 12 ENTERPRISE-WIDE DEPLOYMENT DOMINATES THE MARKET
  • 4.3 ASIA PACIFIC CLINICAL TRIAL MANAGEMENT SYSTEM MARKET
    • FIGURE 13 LARGE PHARMA-BIOTECH COMPANIES FORM THE LARGEST END-USER SEGMENT IN THE ASIA PACIFIC MARKET
  • 4.4 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY REGION
    • FIGURE 14 APAC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2020-2025)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 15 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Significant operational costs and regulatory requirements associated with clinical research
      • 5.2.1.2 Research partnerships between pharma-biopharma companies and CROs
      • 5.2.1.3 The rising number of clinical trials and the availability of advanced CTMS solutions
      • 5.2.1.4 Expansion of the target customer base
      • 5.2.1.5 Rising government funding and grants to support clinical trials
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Budget constraints
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing outsourcing of research processes
      • 5.2.3.2 Greater integration with Platform-as-a-service (PaaS) and mobile computing
      • 5.2.3.3 Investment in effective digital infrastructure and agility in technological adoption
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of skilled professionals
      • 5.2.4.2 Fragmented and highly regulated industry
      • 5.2.4.3 Patient privacy
      • 5.2.4.4 Limited awareness among researchers about associated advantages
    • 5.2.5 KEY TRENDS
      • 5.2.5.1 Integration of CTMS with software such as HIS, EMR, and EDC
      • 5.2.5.2 Mergers and acquisitions
      • 5.2.5.3 Shift from manual data interpretation to real-time data analysis during clinical studies
  • 5.3 IMPACT OF COVID-19 ON THE CLINICAL TRIAL MANAGEMENT SYSTEM MARKET
  • 5.4 ECOSYSTEM COVERAGE: PARENT MARKET (HEALTHCARE IT SOLUTIONS)
    • 5.4.1 ECOSYSTEM COVERAGE: CTMS MARKET
  • 5.5 MAJOR USE CASES: PARENT MARKET (LIFE SCIENCE ANALYTICS SOLUTIONS)

6 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT TYPE

  • 6.1 INTRODUCTION
    • TABLE 1 CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
  • 6.2 ENTERPRISE-WIDE CTMS
    • 6.2.1 ENTERPRISE-WIDE CTMS IS PREFERRED BY END USERS
    • TABLE 2 ENTERPRISE-WIDE CTMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 6.3 ON-SITE CTMS
    • 6.3.1 ON-SITE CTMS SUPPORTS IMPROVED CLINICAL TRAILS
    • TABLE 3 ON-SITE CTMS MARKET, BY REGION, 2018-2025 (USD MILLION)

7 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY DELIVERY MODE

  • 7.1 INTRODUCTION
    • TABLE 4 CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
  • 7.2 WEB-BASED (ON-DEMAND) CTMS
    • 7.2.1 PROVISION OF CENTRALIZED MANAGEMENT IN CLINICAL TRIALS TO AID THE ADOPTION OF WEB-BASED CTMS
    • TABLE 5 WEB-BASED (ON-DEMAND) CTMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.3 LICENSED ENTERPRISE (ON-PREMISES) CTMS
    • 7.3.1 MINIMIZED RISK OF DATA BREACHES AND EXTERNAL ATTACKS SUPPORTS THE USE OF ON-PREMISES CTMS MODELS
    • TABLE 6 LICENSED ENTERPRISE (ON-PREMISES) CTMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.4 CLOUD-BASED (SAAS)
    • 7.4.1 HIGH ADAPTABILITY AND RELIABILITY TO AID ADOPTION OF CLOUD-BASED SOLUTIONS
    • TABLE 7 CLOUD-BASED (SAAS) CTMS MARKET, BY REGION, 2018-2025 (USD MILLION)

8 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY PRODUCT & SERVICE

  • 8.1 INTRODUCTION
    • TABLE 8 CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • 8.2 SOFTWARE
    • 8.2.1 RISING NUMBER OF CLINICAL TRIALS TO SUPPORT MARKET GROWTH
    • TABLE 9 CTMS MARKET FOR SOFTWARE, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 SERVICES
    • 8.3.1 NEED FOR CONTINUOUS UPGRADATION OF CTMS SOFTWARE HAS INCREASED THE DEMAND FOR SERVICES
    • TABLE 10 CTMS MARKET FOR SERVICES, BY REGION, 2018-2025 (USD MILLION)

9 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 11 CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.2 LARGE PHARMA-BIOTECH COMPANIES
    • 9.2.1 LARGE PHARMA-BIOTECH COMPANIES DOMINATE THE END-USER MARKET
    • FIGURE 16 ACTIVE PHARMACEUTICAL PIPELINE, 2009-2019
    • TABLE 12 CTMS MARKET FOR LARGE PHARMA-BIOTECH COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • 9.3 CONTRACT RESEARCH ORGANIZATIONS
    • 9.3.1 RISING OUTSOURCING AND GROWING CRO PRESENCE ARE KEY GROWTH DRIVERS
    • TABLE 13 CTMS MARKET FOR CROS, BY REGION, 2018-2025 (USD MILLION)
  • 9.4 MEDICAL DEVICE MANUFACTURERS
    • 9.4.1 NEED TO COMPLY WITH REGULATIONS AND ENSURE PRODUCT SAFETY AND QUALITY HAVE SUPPORTED USE OF CTMS
    • FIGURE 17 R&D SPENDING OF LEADING MEDICAL DEVICE COMPANIES (2018)
    • TABLE 14 CTMS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2025 (USD MILLION)
  • 9.5 SMALL & MID-SIZED PHARMA-BIOTECH COMPANIES
    • 9.5.1 RISE IN OUTSOURCING TO SMALLER PHARMA COMPANIES IS A KEY DRIVER OF MARKET GROWTH
    • TABLE 15 CTMS MARKET FOR SMALL & MID-SIZED PHARMA-BIOTECH COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • 9.6 OTHER END USERS
    • TABLE 16 CTMS MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)

10 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 17 CTMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 18 NORTH AMERICA: CTMS MARKET SNAPSHOT
    • TABLE 18 NORTH AMERICA: CTMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 19 NORTH AMERICA: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 20 NORTH AMERICA: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 21 NORTH AMERICA: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 22 NORTH AMERICA: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 The US holds the largest share of the North American market
    • TABLE 23 NUMBER OF CLINICAL TRIALS STARTED IN THE US, BY COMPANY, 2017
    • TABLE 24 US: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 25 US: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 26 US: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 27 US: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Preference of pharmaceutical companies to conduct clinical trials in Canada to support market growth
    • TABLE 28 CANADA: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 29 CANADA: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 30 CANADA: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 31 CANADA: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 32 EUROPE: CTMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 33 EUROPE: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 34 EUROPE: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 35 EUROPE: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 36 EUROPE: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 High investments and initiatives in Germany to boost market growth
    • TABLE 37 GERMANY: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 38 GERMANY: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 39 GERMANY: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 40 GERMANY: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Favorable R&D scenario in the country to boost software adoption
    • TABLE 41 UK: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 42 UK: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 43 UK: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 44 UK: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 High number of oncology clinical trials in France to drive market growth
    • TABLE 45 FRANCE: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 46 FRANCE: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 47 FRANCE: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 48 FRANCE: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Low drug approval times have driven the adoption of CTMS, supporting market growth
    • TABLE 49 NUMBER OF CLINICAL TRIALS STARTED IN ITALY, BY COMPANY, 2017
    • TABLE 50 ITALY: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 51 ITALY: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 52 ITALY: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 53 ITALY: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Rising R&D expenditure to propel the growth of the Spanish market
    • TABLE 54 SPAIN: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 55 SPAIN: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 56 SPAIN: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 57 SPAIN: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 58 ROE: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 59 ROE: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 60 ROE: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 61 ROE: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 19 APAC: CLINICAL TRIAL MANAGEMENT SYSTEM MARKET SNAPSHOT
    • TABLE 62 ASIA PACIFIC: CTMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 63 ASIA PACIFIC: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 64 ASIA PACIFIC: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 65 ASIA PACIFIC: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 66 ASIA PACIFIC: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 Low cost of clinical trials and large pharmaceutical R&D base in China to drive market growth
    • TABLE 67 CHINA: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 68 CHINA: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 69 CHINA: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 70 CHINA: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Stringent regulatory scenario in Japan to restrain the market growth
    • TABLE 71 JAPAN: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 72 JAPAN: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 73 JAPAN: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 74 JAPAN: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Favorable pharmaceutical R&D scenario to drive software adoption
    • TABLE 75 INDIA: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 76 INDIA: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 77 INDIA: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 78 INDIA: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Government support for clinical trials to boost the market in Australia
    • TABLE 79 AUSTRALIA: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 80 AUSTRALIA: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 81 AUSTRALIA: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 82 AUSTRALIA: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Growth of the contract research sector indicates opportunities for CTMS providers
    • TABLE 83 SOUTH KOREA: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 84 SOUTH KOREA: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 85 SOUTH KOREA: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 86 SOUTH KOREA: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 87 ROAPAC: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 88 ROAPAC: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 89 ROAPAC: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 90 ROAPAC: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 10.5 LATIN AMERICA
    • 10.5.1 RISING INVESTMENTS AND HEALTHCARE EXPENDITURE SHOW POTENTIAL FOR MARKET GROWTH
    • TABLE 91 LATAM: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 92 LATAM: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 93 LATAM: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 94 LATAM: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 10.6 MIDDLE EAST AND AFRICA
    • 10.6.1 GROWING AVAILABILITY OF FUNDING IN THE MIDDLE EAST INDICATES OPPORTUNITIES FOR MARKET GROWTH
    • TABLE 95 MEA: CTMS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 96 MEA: CTMS MARKET, BY DEPLOYMENT MODE, 2018-2025 (USD MILLION)
    • TABLE 97 MEA: CTMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 98 MEA: CTMS MARKET, BY END USER, 2018-2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
    • FIGURE 20 KEY DEVELOPMENTS IN THE CLINICAL TRIAL MANAGEMENT SYSTEM MARKET (2017-2020)
  • 11.2 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM MARKET SHARE ANALYSIS (2019)
    • FIGURE 21 ORACLE HELD THE LEADING POSITION IN THE CLINICAL TRIAL MANAGEMENT SYSTEM MARKET IN 2019
  • 11.3 COMPETITIVE SCENARIO (2017-2020)
    • 11.3.1 KEY PRODUCT LAUNCHES AND PRODUCT DEPLOYMENTS (2017-2020)
    • 11.3.2 KEY EXPANSIONS (2017-2020)
    • 11.3.3 KEY MERGERS, DIVESTITURES, AND ACQUISITIONS (2017-2020)
    • 11.3.4 KEY AGREEMENTS, CONTRACTS, AND PARTNERSHIPS (2017-2020)
  • 11.4 COMPETITIVE LEADERSHIP MAPPING
  • 11.5 VENDOR INCLUSION CRITERIA
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 22 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019
  • 11.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/ START-UPS (2019)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 23 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019 (SMES/START-UPS)

12 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, MnM View)**
  • 12.1 ORACLE
    • FIGURE 24 ORACLE: COMPANY SNAPSHOT
  • 12.2 MEDIDATA SOLUTIONS
    • FIGURE 25 MEDIDATA SOLUTIONS: COMPANY SNAPSHOT
  • 12.3 PAREXEL INTERNATIONAL CORPORATION
  • 12.4 IBM
    • FIGURE 26 IBM: COMPANY SNAPSHOT
  • 12.5 BIOCLINICA
  • 12.6 BIO-OPTRONICS
  • 12.7 DATATRAK INTERNATIONAL
    • FIGURE 27 DATATRAK INTERNATIONAL: COMPANY SNAPSHOT
  • 12.8 VEEVA SYSTEMS
    • FIGURE 28 VEEVA SYSTEMS: COMPANY SNAPSHOT
  • 12.9 MASTERCONTROL
  • 12.10 DSG
  • 12.11 ERT
  • 12.12 ADVARRA TECHNOLOGY SOLUTIONS
  • 12.13 MEDNET SOLUTIONS
  • 12.14 ARISGLOBAL
  • 12.15 DZS CLINICAL SERVICES (WDB HOLDINGS CO. LTD)
  • 12.16 EMERGING PLAYERS/START-UPS
    • 12.16.1 CRUCIAL DATA SOLUTIONS (CDS)
    • 12.16.2 ENNOV
    • 12.16.3 DATASTAT
    • 12.16.4 BSI
    • 12.16.5 REALTIME SOFTWARE SOLUTIONS LLC
  • *Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 RESEARCH DATA
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS